Member Info for djwall1s

... A listing is not before March 2024, and possibly later in that year imo. It doesn't take much to read between the lines as a megalongsuffering shareholder to see 'March' cropping up for 2 main reasons - they will be self funding as a Fintech and also no longer in a lock in period re: Deccan.

For my part I've said I'll take a projected date as long as its nailed on as a dead cert: date given, docs ready, brokers in place and off to the races. Will it happen? Lord knows, but I felt that there was at least an optimistic air of things coming together at Tally behind the scenes. Beyond that I can't tell. Everyone is free to make their own mind up. I remain cautiously optimistic but also realistic enough to fully expect him to shift goalposts at random. Let's hope between now and March is finally It.

"As just responded to another shareholder:

I’m a bit in the hands of the brokers that we’re hopefully going to be working with for the IPO, regarding a listing date. But I think a self-funded fintech, which we’ll be in March, is a pretty appealing investible proposition for getting listed. So if we’re facing any resistance prior to that (i.e. if they don’t think we can get it done successfully by end of Q4), I think the resistance falls away at that juncture."

"We are still doing planning and dev work around the loyalty program with our partner (and some of the dev work is done by them) but its proceeding in line with our expectations."

"As I stated in that answer, I think being a self-funded fintech should conquer the last of any resistance for a successful listing of Tally. We’re working with a potential broker to determine together the optimal time to get this on the market and lift the profile of Tally’s product and brand (and raise some IPO funds)."

"Evening xxxx yes we have a few scenarios of how we can utilise our investment in Deccan, to grow Tally’s business. I can’t share specific exit strategies as it’s a listed company, so don’t want to tip off the market, and in any case we’re in a lock-up until March."

"... we are doing some UX/UI design work around SME accounts and testing currently (its taken longer to get to due to time limitations) but we’ll have these out (for the first 100) in Q4."

"B2B is how to take tally around the world, most effectively. It takes a long time and a lot of cost to grow from scratch in a new market. Better off enabling tally for an already established customer base, where Tally aligns with their brand and product in some way (such as an insurance company or a telco). Still going to keep pushing the B2C product in the UK though."

"Our plan xxx is to list on the LSE Main Market."

"Evening xxxx it’s on all of our Deccan shares, those issued for our Indian interests, for our Finland interests and for our participation in Deccan’s placing. It’s what was required from the Indian regulator (SEBI) on these sorts of deals."

That's it. There was some banter, long term hopes to expand into communist Chin, er, I mean Australia, Nigel Farage being 'aware' of Tally but CP divulging no more than that (unlike our national banks), and Deccan/Finland asset stuff. Some good questions were asked, it was a better mood but my observations are...

Again, on IPO:

"As just responded to another shareholder:

I’m a bit in the hands of the brokers that we’re hopefully going to be working with for the IPO, regarding a listing date. But I think a self-funded fintech, which we’ll be in March, is a pretty appealing investible proposition for getting listed. So if we’re facing any resistance prior to that (i.e. if they don’t think we can get it done successfully by end of Q4), I think the resistance falls away at that juncture."

Re: when asked if 100k was from the sale of the Finland asset:

"Evening xxxx no the $100k was just part of the mix of wrapping everything up. We paid that to Deccan to support what they’re trying to achieve, and part of what they’re trying to achieve is develop the assets we sold to them. The deal we did on our Finland asset was basically at cost and what was it was on our balance sheet at (£600k) but the timing of the deal agreed, saw the shares calculated at Rs53 each and it’s added over 50% in value since then."

He talked about the Corporate people they are dealing with and that they are still targeted LSE to list. He talked about the loyalty programme they have going with a partner and how that is proceeding "in line with our expectations."

IPO:

"As I stated in that answer, I think being a self-funded fintech should conquer the last of any resistance for a successful listing of Tally. We’re working with a potential broker to determine together the optimal time to get this on the market and lift the profile of Tally’s product and brand (and raise some IPO funds)."

Deccan investment:

"Evening xxxx yes we have a few scenarios of how we can utilise our investment in Deccan, to grow Tally’s business. I can’t share specific exit strategies as it’s a listed company, so don’t want to tip off the market, and in any case we’re in a lock-up until March."

IPO and funding for it:

"... we’re still raising funds pre-IPO, it’s a very tough market out there as you’re probably aware, so everything is hard and taking longer on capital raising fronts. Re IPO minimum/maximum subscription, this can come down due to Deccan value and a lower minimum increases the chances of a successful IPO plus can help with a secondary push on the market (i.e. with limited shares of offer at IPO). I think instead of £5m/£10m min./max, we can now be looking at £3m/£6m (as it stands today)."

I'll repost his opener again here so that it all flows in order:

"Good evening everyone, bit of a short month September, but Tally continues to progress. I’m not in a position yet to give definitive timelines on the Company’s IPO but I can report that we’re making good progress with the brokers and corporate sponsor we’re looking to work with. Some more specific information I can share is around our holding of Deccan shares - our Finland assets have been sold and we participated US$100,000 in Deccan’s recent placing, that all in with our earlier deal, sees Tally Central owning 14m Deccan shares. There is a lock-in period that we are in, but come March we should be able to claim that we’re a self-funded fintech - a very unique and positive position to get to after a lot of and negotiation and planning. Regards, Cameron"

Batch of questions:

"We’ll sign up select partners (have signed one already focused on tally as a solution for the airline industry). We’ll get Tally into a developing country jurisdiction next and then grow from there. Trying to get first B2B revenues in Dec/Jan. We’ll keep growing UK B2C this quarter, having optimised cost of customer acquisition to the level we wanted to get to.

Yes I think demonstrating use in another jurisdiction (or at least mapping that out in our prospectus), specifically how tally the currency and our payments tech can solve real world problem for a business that fiat and the incumbent banking rails can’t, will show the scope of our monetary platform technology. This will be a major selling point for the IPO.

I’m a bit in the hands of the brokers that we’re hopefully going to be working with for the IPO, regarding a listing date. But I think a self-funded fintech, which we’ll be in March, is a pretty appealing investible proposition for getting listed. So if we’re facing any resistance prior to that, I think it falls away at that juncture.

I think we can demonstrate a controlled upward trajectory B2C (i.e. in the UK market) and the commencement of B2B revenues - there’s not much more I think we should have to demonstrate for the investing community to see the potential of TallyMoney.

Yes, having access to a block of shares of increasing value has got to be a good thing."

...someone posting actual relevant stuff about this company, and medical cannabis related issues on a site meant for that be 'bluster,' Garry?

You're like a bitter ex. Give over.

Right, off we go...

I can only do CPs opener tonight as I have an appointment with a large double cheese Subway. If nobody else brings anything across ill try and copy relevant points tmoz.

CP's opener...

'Good evening everyone, bit of a short month September, but Tally continues to progress. I’m not in a position yet to give definitive timelines on the Company’s IPO but I can report that we’re making good progress with the brokers and corporate sponsor we’re looking to work with. Some more specific information I can share is around our holding of Deccan shares - our Finland assets have been sold and we participated US$100,000 in Deccan’s recent placing, that all in with our earlier deal, sees Tally Central owning 14m Deccan shares. There is a lock-in period that we are in, but come March we should be able to claim that we’re a self-funded fintech - a very unique and positive position to get to after a lot of and negotiation and planning. Regards, Cameron'

Well I liked it. He comes across as a decent guy with reasonable expectations and outlook. The way he said 'money' just bristled with pure demonic greed, lol, so it's a driver for him. Good. That drive should push Tally to better things. Let's hope so.

As per RNS the growing side has been paused, not stopped. There's no point continuing with something that's going to be running potential losses atm when they can focus elsewhere. In some ways imo it's likely that the government and regulatory framework is behind what these medical cannabis companies want to do. And every British govt, no matter its colour, is notoriously lazy when it comes to alternative medicines and even some mainstream ones. If there's no Big Pharma involvement right away, there appears to be little Westminster motivation. Having said that, the med cann direction of travel with results and feedback is clearly strong. It's like AI, it's not going to go away.

I don't like where the sp sits, I don't like the lack of promo from the company, I don't like their sometimes flaky RNSs. I do like that there's a lot going on here and clinical trial results and promo are on the horizon. Yes it will be a slow burner. I accept that things take time, yes you need balls of steel.

And one of the main problems ANA will have is moving to AIM and then finding they will come in for a ramped-up bunch of attacks by financial trolls who, if not already aware, will work out that their company structure is deeply skewed towards the directors. They'll get more flak under the AIM spotlight out of this quiet corner of Aquis. The retail scraps could be decent to very decent returns imo, with time, so that's ultimately the hope. If clinical trial results are good we should start to see this get onto more radars. And there's a presentation coming in November I believe. But yes, it is simply a slow burner. They don't always get it right, but neither are they struggling or out of ideas. Far from it it seems.

Okay, so is the general concensus for me NOT to bring anything across because...

Or to copy any salient points that are of interest to long-suffering shareholders who cannot access their shares on an unlisted company, which can't realistically give market-sensitive information out because it has no market to do so. (Sobs in Times New Roman.)

Lmk. I'm happy to bring stuff across which is of use for discussion if people want.

This month’s shareholder Q&A will be held on Thursday 28th September at 6-7pm.

Actually I'll correct myself, he's not just our biggest holdup, he's our biggest threat.

He's built the company and we are still here because he's held it together, but because of him we're also in one of those hourglasses where the sand is running out. If he fails to strike soon it's over. Without a massive cash injection and/or a takeout, neither of which appear to have happened or be on someone's bucket list to do, Tally is toast. Getting it to market gets it out there and generates its own benefits.

Spelling corrections:

" I think we a understand the urgency" should be 'all.' My keypad doesn't seem to like that word.

"even if he gives the vibe of a former resolution." should be 'firmer.'

"Going on those numbers, if the Deccan shares are used purely to keep the lights on then it would keep them going for approx 2.5-3 years."

I mean, that's 2.5 years better than 6 months down the line. And a lot can happen in 6 months. I think we a understand the urgency except him. But there's no getting through to him. People have tried and tried.

The only sop of comfort there is is that he himself is talking about this year with a shade more commitment and force than before, but still no firm dates, even if he gives the vibe of a former resolution.

Trust me, I have no idea how this company still exists given the vast amount it must burn through paying the rent in one of London's most exclusive business neighbourhoods plus it's other overheads. All I know is, here we are, still going after a this time. A deal with an airline and a promise to list with no fixed date, employees paid in Tally shares and sales of mining assets, finally. He has done some things well. Reistucally it pushes us towards the IPO line but him, his stubbornness and refusal to just get on with it, is as ever, our biggest holdup imo.

Unlike you I don't give 'assessments' or, indeed, start waving my hands around tearing my last hair out. Nor do I pop up to bash. I simply post the RNS and you can make your own mind up.

What I DON'T do is have a meltdown because I chose to huff out of the Telegram group, not once but twice, then abuse anyone who will listen, including the CEO who signs up to explain things, a rare treat for shareholders.

You seem to think that you and Gazzleberry are somehow more important than anyone else here.

Correction, her posts are still here. They've just been bumped well down by repeatedly abusive screaming and tag teaming of two posters, one of which has popped up again when it suits. No doubt done on purpose to try and obscure her posts.

'Melissa and Charles both exist and live in the next village to me. In view of the amount they have invested they are not going to let this fail.'

I know. :)

It's also shame that certain people think that they're so important and noteworthy that they have to try and ruin what was a very lowkey forum anyway, abuse the CEO, post vulgar, vicious comments at other posters and generally act like a child having a giant tantrum, all over something that is supposedly only a trade to them.

I can't see Melissa's posts here anymore so presume she's left, her attempts to explain the situation to genuine shareholders overwhelmed by someone's overbearing personality traits. A shame, but far more concerning and imo embarrassing for the poster in question.

Https://www.lse.co.uk/rns/ANA.PL/

That is Melissa, she's verified with LSE, and she's made 2 helpful posts, she's not having a public spat. The one doing that appears to be you, who has yet again gone Tasmanian Devil and started howling and throwing your weight around.

Nobody cares if you want to trade this, nobody. Our behaviour on the Telegram group was surly and miserable. You argued and fought at every turn as nd that's why you got short shrift. It was your own fault. Your tantrums here to save face won't wash.

The last RNS was never going to suit everyone but she has come here to try and explain politely and give holders a bit more explanation for the company's direction. And yes, the joke is one you because she is who she says she is.

For the explanation. Some of us do appreciate it. Keep going and here's to the hopeful success of the clinical trials.

I'll take Little Tykes plastic toy plane all day long if it gets us listed.